[1] 中华医学会肝病学分会和中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [2] Liang XF,Bi SL,Longd WZ,et al. Epidemiological serosurvey of hepatitis B in China:Declining HBV prevalence due to hepatitis B vaccination.Vaccine,2009,27(47):6550-6557. [3] Liang XF,Bi SL,Yang WH.et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis,2009,200(1):39-47. [4] Pon Zetto A,Pellieano R,Leone N,et al. Helicobaeter pylorieropreva-lance in cirrhotic patients with hepatitis B virus infection. Neth J Med,2000,56(6):206-210. [5] EI-masry S,EI-Shahat M,Badra G. Helicobacter pylori and hepatitis C virus coinfection in Egyptian patients. J Glob Infect Dis,2010,1(2):914-923. [6] Baldari CT,Lanzavecchia A,Telford JL. Immune subversion by Helicobacter pylori. Trends Immunol,2005,26(4):199-207. [7] 邓庆文,罗亮. 根除幽门螺杆菌对不同程度慢性乙型病毒性肝炎患者的影响. 中国医师杂志,2009,11(10):1424-1428. [8] 卢琳琳,胡东胜,刘冬娜. 肝硬化HP感染者血清细胞因子和内毒素水平测定的临床意义. 实用肝脏病杂志,2009,12(3):218-219. [9] 杜建新,蒋锦,华芦红. 门脉高压性胃病患者幽门螺杆菌感染率调查. 实用肝脏病杂志,2012,15(1):32-33. [10] 王甦,李翠,陈凤娟,等. 乙肝相关性肝病患者幽门螺杆菌感染的研究. 实用临床医药杂志,2013,11(3):39-42. [11] 季尚玮,王江滨,张永贵.慢性乙型肝炎患者肝组织中螺杆菌菌属特异性1 6SrRNA基因及Hp特异性基因分析. 肝脏,2009,14(6):449-452. [12] 库热西江·托呼提,哈木拉提·吾甫尔,张利占,等. 和田地区维吾尔族、汉族人群HBsAg携带率的流行病学调查分析. 第一军医大学学报,2004,24(11):1287-1288. [13] 中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南. 中华肝脏病杂志,2006,14(11):866-870. [14] 陈文彬,潘祥林,康熙雄. 诊断学. 北京:人民卫生出版社,2004:389. [15] 彭文伟,李兰娟,乔兴彦.传染病学. 北京:人民卫生出版社,2003:33. [16] Fox JG,Dewhirst FE,Tully JG,et al. Helicobacter hepaticus sp. nov,a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol,1994,32:1238-1245. [17] Chen SJ,Wang IJ,Zhu Q,et a1. Effect of Hpylori infect and its eradication on hyperammonemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol,2008,14(12):1914-1918. [18] Nilsson HO,Taneera J,Castedal M,et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization,and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliarycirrhosis. J Clin Microbiol,2000,38(3):1072-1076. [19] Rocha M,Avenaud P,Menard A,et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut,2005,54:396-401. [20] 艾斯凯尔﹒ 阿斯木,麦麦提﹒ 图尔荪,麦麦提﹒ 买地尼也提,等.新疆维、汉、哈族有消化道症状患者幽门螺旋杆菌感染率分布特征与高危因素及相关疾病的分析.新疆医学,2012,42(1):4-9. [21] 柯柳,温小凤,蒋忠胜,等. 幽门螺杆菌感染与慢性乙型肝炎患者肝脏炎症及纤维化的关系.山东医药,2012,52(13):52-54. [22] 庞念德,陈安海. 乙型肝炎病毒及幽门螺杆菌感染对慢性乙型肝炎患者胃粘膜病变的影响. 河北医学,2014,20(12):1964-1968. [23] Ge Z,Rogers AB,Feng Y,et al. Bacterial cytolethal distending toxin pro -motes the development of dysplasis in a model of microbially indeced hepatocarcinogenesis. Cell Microbiol,2007,9(8):2070-2080. |